BNF:

5.3.3

Status:

Red

Decision Date:

March 2015

Comments

RED: NICE TA 330:Hepatitis C treatment.

Commissioning responsilibilty falls within the remit of NHS England.

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
• 4: Specifically designated as “hospital only” by product licence or by DH/NICE

search again